Results 241 to 250 of about 17,182,321 (391)

Stem cell therapy in systemic sclerosis. [PDF]

open access: yesClin Rheumatol
Sakkas LI   +4 more
europepmc   +1 more source

TRPM8 levels determine tumor vulnerability to channel agonists

open access: yesMolecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo   +18 more
wiley   +1 more source

Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy? [PDF]

open access: yesAntibodies (Basel)
Matarneh A   +7 more
europepmc   +1 more source

Stem Cell Therapy- An Overview

open access: gold, 1970
Aishwarya Goud Jagiri   +3 more
openalex   +2 more sources

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Stem cell therapy for diabetes: Advances, prospects, and challenges. [PDF]

open access: yesWorld J Diabetes
Zuo DB   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy